ARTELLA Solutions specializes in Remote Patient Monitoring with a primary focus of Mobile Cardiac Telemetry (MCT) which involves a wireless cardiac patch to transmit ECG information for real-time alert monitoring and ECG reporting. Cardiac events are monitored and responded to in real-time, 24 hours a day by trained technicians who provide medical analytics to the prescribing physician. Physicians will receive 2 reports: a “24-hour” report and an “end of study” report when the prescribed period is completed.
ARTELLA also provides a unique Elite Customer Service model which provides a concierge service for patients receiving our service. The ARTELLA Customer Service Representative will assist patients and clinic staff by providing application of the MCT system at the clinic, the patient’s home or via video conferencing (telemedicine). ARTELLA provides Software as a Service and Service as a Solution.
The Company, founded by Leo Womack in 2018, is a distributor of a Mobile Cardiac Telemetry (MCT) reporting system.* The Company began marketing the MCT system with an Elite Customer Service Model and is credentialed as an Independent Diagnostic Testing Facility (IDTF). As of May 2020, the Company became ARTELLA Solutions with control of its own MCT reporting system.
*The company was formerly known as CorVitals of Texas.
Leo Womack began his career as a CPA with Arthur Anderson, leaving four years later to purchase and build a local CPA firm which he merged it into a national firm ten years after the purchase. During that same time period, Mr. Womack co-founded the 376-bed Park Plaza Hospital that was sold for a significant gain eight years later, which led him to a continued focus in real estate investing and development. Among numerous projects, his development group successfully redeveloped nine historical buildings in the San Antonio CBD, including the iconic Main Plaza Building.
Throughout his career, Mr. Womack has sought to invest in exceptional people and companies, where he maintains a leadership role in financial planning and execution. Currently, this is accomplished through his position as CEO of Ramsey Financial Group (operating as a family office (http://www.ramseyfg.com) where he manages and controls the investment portfolio of his family trust. The firm and trust were established in 1992 and the investments within the trust are diversified into real estate and private and public companies.
For over 30 years, Mr. Womack has been president of Gulf Equities Realty Corp. The firm manages a significant portfolio (www.gulfequities.com) of real estate assets in the greater Houston area.
More recently Mr. Womack became the chairman of Petrolia Energy Corporation, (http://www.petroliaenergy.com) a small oil and gas company with a business strategy of acquiring proven, producing reserves, using technology to enhance reserve recovery.
Mr. Womack is the founder of CorVitals of Texas, Inc. and serves as its Chairman of the Board.
Michael A Torres
Michael Torres is a high-performing, versatile executive with 27 years of medical/healthcare experience. Over his career, Michael has honed his skills in multiple roles as a senior sales and marketing leader who can identify and capitalize on market opportunities to drive revenue. He has demonstrated vital leadership capabilities through the successful launch of 10 products in heavily competitive markets in various therapeutic areas (including 4 in cardiovascular markets).
Michael began his career with a Merck startup company (AstraMerck) for the launch of Prilosec holding positions in field sales, sales analytics, operations, marketing and sales management. Michael also held cardiovascular management positions with Biovail and Schwarz Pharma where he developed teams from the bottom to the top of their respective sales forces. In recent years, while at Ferring USA, he was responsible for sales, brand P&L, VA/DOD accounts, managed care, and Integrated Health Systems/IDNs, within the buy-and-bill and specialty (prescription) markets.
Michael intimately understands the core dynamics for marketing newly emerging products, especially the critical role of brand awareness, brand retention and product positioning in highly competitive markets. At Ferring, he was a key leader in a start-up organization and drove strategic planning to rapidly launch their Class III medical device (EUFLEXXA). His expertise was vital aligning regions & territories and coordinating vital support (training, market tools and incentive compensation plans) as Director of Sales Force Effectiveness.
Having spent his career delivering stakeholder value through people, he utilizes sound, strategic sales and marketing blue-prints to achieve success. His expertise will bring prosperous product launches for ARTELLA Solutions in the immediate future. He joined the company in April 2019 as Executive VP of Sales and Marketing and accepted the role of President in December 2019.
Michael graduated from Lamar University with a Bachelor of Arts and Science degree. Michael and his wife Donna reside in Houston, Texas with their twin daughters - Gemma and Grace.
Steven M. Plumb is a CPA and serial entrepreneur with a focus on life science companies. He began his career as a CPA with KPMG, moving on to become the CFO of a for profit hospital and later for a large non profit organization. Mr. Plumb started his own consulting firm offering interim CFO services to start up and early stage companies in both the private and public spaces.
Since that time Mr. Plumb has served as the CFO of a number of life science companies, including AdventRX Pharmaceuticals, HoustonPharma, Complexa, and others and has founded three life science companies, one online vocational training company and an urgent care center. He has extensive experience raising capital in the public and private markets and taking companies public. Mr. Plumb is a graduate of the University of Texas at Austin with a Bachelors in Business Administration degree in accounting.
Sepand Moshiri -Sep- is a data driven executive and board member with over 20 years of consultative selling and strategic leadership, corporate turnaround, and client operations achievements in the medical devices, disruptive SaaS platform technology, value-based healthcare & services, Big Pharma, and capital markets industries. Sep also built the first and only Elite Customer Service (concierge) model in the Mobile Cardiac Telemetry (MCT) industry.
Involved in various phases of start-ups, funding and acquisitions, Sep serves as a change agent within the cardiovascular innovations industry while executing tactical problem solving solutions. In 2010, he was instrumental in the creation of CardioNexus Corporation (Fairway Medical Technologies & Panasonic NA) to deploy an innovative diagnostic platform. From 2018-19, Sep served as the President of CorVitals of Texas Inc. (now, ARTELLA Solutions Inc.), the pioneering MCT monitoring and Digital Health organization which he co-founded. Currently, he is the Managing Director of Ramsey Financial Group (RFG), a single-family office which manages the Leo B. Womack Family Trust companies and largest shareholder of ARTELLA.
Within management roles in both the Cardiology/Urology and US Government Relations divisions at Pfizer, Inc., Sep developed multi-faceted teams in preparation for launches of emerging first-in-class products throughout leading healthcare systems including VA Medical Centers and The Texas Medical Center. This propelled his significant long-term value at complex matrix medical device organizations. Through his consulting and sales executive roles, Sep led business turnaround in various healthcare entities, while enforcing sweeping departmental changes coupled with growing P&L responsibility.
Sep was a founding shareholder and built the Client Operations vertical of the unique mobile 3D Mammography imaging network, Covia Health, whose mission was to define preventative healthcare in women within large-cap employers. At the Utilization Management company WNS-HealthHelp, he oversaw a $60M P&L and led a high performing group to manage 5.2M lives for its largest client, Humana, Inc., while negotiating large Medicare and Commercial Insurance contracts. This served as a precursor to founding and establishing ARTELLA as an Independent Diagnostic Testing Facility (IDTF) to achieve In-Network status with all Payors.
Sep is a Houston Chapter Founder and Co-Chair, Sponsorship Committee of the Private Directors Association (PDA); Board Member at Fairway Medical Technologies; Board Member at ARTELLA; Board Director at Liprostin Group; Business Advisory Board at RedCrow (direct investment platform).
Sep received a Bachelor of Science in Neurobiology with honors from Vanderbilt University and an MBA with highest honors from University of Houston C.T. Bauer College of Business.